Eli Lilly and Company, which manufactures one of the new weight-loss drugs, has launched an advertising campaign reinforcing that the drugs should not be used for cosmetic weight loss.
A new International Diabetes Federation position statement calls for improved prediction of type 2 diabetes in high-risk individuals using a 1-hour glucose tolerance test.
Patients on a weekly GLP-1 RA had a higher prevalence of increased residual gastric content before surgery, a major risk factor for aspiration under anesthesia, a small study found.
Higher weekly levels of moderate physical activity were linked to proportionally lower risks for CKD in adults with T2D and obesity or overweight, a new study showed.